ACANTHE DEVELOPPEMENT SA (ACAN.PA) Fundamental Analysis & Valuation

EPA:ACAN • FR0000064602

Current stock price

0.22 EUR
0 (-0.45%)
Last:

This ACAN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ACAN.PA Profitability Analysis

1.1 Basic Checks

  • ACAN had negative earnings in the past year.
  • In the past year ACAN has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ACAN reported negative net income in multiple years.
  • Of the past 5 years ACAN 4 years had a positive operating cash flow.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

  • ACAN's Return On Assets of -1.57% is on the low side compared to the rest of the industry. ACAN is outperformed by 82.93% of its industry peers.
  • ACAN has a Return On Equity of -1.87%. This is in the lower half of the industry: ACAN underperforms 78.05% of its industry peers.
  • The Return On Invested Capital of ACAN (0.35%) is worse than 87.80% of its industry peers.
Industry RankSector Rank
ROA -1.57%
ROE -1.87%
ROIC 0.35%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • ACAN has a worse Operating Margin (16.00%) than 85.37% of its industry peers.
  • In the last couple of years the Operating Margin of ACAN has grown nicely.
  • ACAN has a Gross Margin (73.58%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of ACAN has remained more or less at the same level.
Industry RankSector Rank
OM 16%
PM (TTM) N/A
GM 73.58%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACAN.PA Health Analysis

2.1 Basic Checks

  • ACAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ACAN has more shares outstanding
  • The number of shares outstanding for ACAN has been increased compared to 5 years ago.
  • Compared to 1 year ago, ACAN has a worse debt to assets ratio.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 2.12 indicates that ACAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACAN (2.12) is better than 100.00% of its industry peers.
  • ACAN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ACAN (0.01) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.04
WACC7.9%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • ACAN has a Current Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ACAN (2.06) is better than 100.00% of its industry peers.
  • ACAN has a Quick Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ACAN (2.06) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 2.06
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ACAN.PA Growth Analysis

3.1 Past

  • ACAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.34%, which is quite impressive.
  • The Revenue has decreased by -5.50% in the past year.
  • ACAN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.49% yearly.
EPS 1Y (TTM)85.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.87%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-9.58%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ACAN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ACAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACAN.PA Dividend Analysis

5.1 Amount

  • ACAN has a Yearly Dividend Yield of 14.45%, which is a nice return.
  • ACAN's Dividend Yield is rather good when compared to the industry average which is at 5.38. ACAN pays more dividend than 97.56% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ACAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.45%

5.2 History

  • The dividend of ACAN decreases each year by -46.74%.
Dividend Growth(5Y)-46.74%
Div Incr Years0
Div Non Decr Years0
ACAN.PA Yearly Dividends per shareACAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2023 2024 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

  • ACAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-134.16%
EPS Next 2YN/A
EPS Next 3YN/A
ACAN.PA Yearly Income VS Free CF VS DividendACAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

More info and screens

Find the best dividend stocksShow peers with best dividend

ACAN.PA Fundamentals: All Metrics, Ratios and Statistics

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (4/28/2026, 7:00:00 PM)

0.22

0 (-0.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-23
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners55.99%
Ins Owner ChangeN/A
Market Cap36.38M
Revenue(TTM)3.73M
Net Income(TTM)-2.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 14.45%
Yearly Dividend0.02
Dividend Growth(5Y)-46.74%
DP-134.16%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.75
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.57%
ROE -1.87%
ROCE 0.48%
ROIC 0.35%
ROICexc 0.35%
ROICexgc 0.35%
OM 16%
PM (TTM) N/A
GM 73.58%
FCFM N/A
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y110.88%
ROICexc growth 3YN/A
ROICexc growth 5Y110.88%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 2.06
Altman-Z 2.12
F-Score4
WACC7.9%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.26%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-9.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y107.12%
EBIT growth 3YN/A
EBIT growth 5Y93.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-178.66%
FCF growth 3YN/A
FCF growth 5Y20.72%
OCF growth 1Y-177.12%
OCF growth 3YN/A
OCF growth 5Y-16.48%

ACANTHE DEVELOPPEMENT SA / ACAN.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ACANTHE DEVELOPPEMENT SA (ACAN.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACAN.PA.


What is the valuation status of ACANTHE DEVELOPPEMENT SA (ACAN.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ACANTHE DEVELOPPEMENT SA (ACAN.PA). This can be considered as Overvalued.


Can you provide the profitability details for ACANTHE DEVELOPPEMENT SA?

ACANTHE DEVELOPPEMENT SA (ACAN.PA) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for ACAN stock?

The dividend rating of ACANTHE DEVELOPPEMENT SA (ACAN.PA) is 5 / 10 and the dividend payout ratio is -134.16%.